← Back to patent-cliff list
CAS 1642581-60-9
1-((6-chloroimidazo[1,2-a]pyridin-3-yl)sulfonyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,3-b]pyridine
Codes: GLUME-005
Application context (from source-drug indications)
Non-small cell lung cancerGlumetinibSolid tumourGlumetinib
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Glumetinib | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
6-bromo-1H-pyrazolo[4,3-b]pyridine→1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole→6-(1-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,3-b]pyridine→6-chloroimidazo[1,2-a]pyridine-3-sulfonyl chloride→1-((6-chloroimidazo[1,2-a]pyridin-3-yl)sulfonyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,3-b]pyridine→Glumetinib
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.